Last reviewed · How we verify

NCT03357965

Familiy Medicine Perspective to Maternal-infant Bonding

Completed Last updated 30 November 2017
What this trial tests

trial testing Questionnaire in Maternal-Fetal Relations in 73 participants. Completed in 1 February 2017.

Timeline
1 December 2016
Primary endpoint
1 February 2017
1 February 2017

Quick facts

Lead sponsorYildiz Atadag
StatusCompleted
Study typeOBSERVATIONAL
Enrollment73
Start date1 December 2016
Primary completion1 February 2017
Estimated completion1 February 2017
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Yildiz Atadag

Who can join

Eligibility, female only, with Maternal-Fetal Relations or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Maternal bonding was described as a qualitative change in the relationship of a mother with her infant. By this study, the investigators aimed to investigate the mother-infant bonding and the factors affecting it, from the point of the family practice, which is responsible for the healthcare of all family members from the fetus to the eldest individual in a family.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Maternal-Fetal Relations

Currently open trials in the same condition.

Other Yildiz Atadag trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03357965.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing